Abalos Raises €12M Series A To Develop Arenavirus-Based Cancer Therapies

 
• By Mike Ward
Euro currency
Abalos Secures Series A Funds For Immuno-Virotherapy Apporach

More from Start-Ups & SMEs

More from Business